(Q45744862)

15 December 2017

title

Crossreactive neutralizing antibodies induced by immunization with caprine arthritis-encephalitis virus surface glycoprotein (English)

1 reference

15 December 2017

0 references

Kemp RK

1

1 reference

15 December 2017

Knowles DP

2

1 reference

15 December 2017

Perry LL

3

1 reference

15 December 2017

McGuire TC

4

1 reference

15 December 2017

Besser TE

5

1 reference

15 December 2017

Cheevers WP

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

issue

13

1 reference

15 December 2017

page(s)

1282-1287

1 reference

15 December 2017

Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

New concepts in the immunopathogenesis of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Can the immune response control HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

The role of the humoral immune response in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Antibody neutralization of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Neutralization of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Recombinant gpl35 envelope glycoproteins of caprine arthritis-encephalitis lentivirus variants inhibit homologous and heterologous variant-specific neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Chronic Arthritis in Goats Caused by a Retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Infectious Leukoencephalomyelitis of Young Goats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Biological Characterization of the Virus Causing Leukoencephalitis and Arthritis in Goats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Erratic G-->A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

North American and French caprine arthritis-encephalitis viruses emerge from ovine maedi-visna viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Transmembrane protein oligomers of caprine arthritis-encephalitis lentivirus are immunodominant in goats with progressive arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Neutralization-Resistant Antigenic Variants of Caprine Arthritis-Encephalitis Lentivirus Associated with Progressive Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Depressed CD4+ T lymphocyte proliferative response and enhanced antibody response to viral antigen in chronic lentivirus-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Failure of neutralizing antibody to regulate CAE lentivirus expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Caprine arthritis-encephalitis lentivirus (CAEV) challenge of goats immunized with recombinant vaccinia virus expressing CAEV surface and transmembrane envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900181-4

7 January 2021

10.1016/S0264-410X(99)00181-4

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017